[Recurrent paralysis induced by vincristine during the treatment of Hodgkin's disease].
Chauffert
B
B
Lorcerie
B
B
André
F
F
Besancenot
J F
JF
Martin
F
F
D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols; D006689:Hodgkin Disease / Q000188:drug therapy; D006801:Humans; D008297:Male; D008466:Mechlorethamine / Q000627:therapeutic use; D010243:Paralysis / Q000139:chemically induced*; D011241:Prednisone / Q000627:therapeutic use; D011344:Procarbazine / Q000627:therapeutic use; D014750:Vincristine / Q000009:adverse effects* / Q000627:therapeutic use
D011344:Procarbazine; D008466:Mechlorethamine; D014750:Vincristine; D011241:Prednisone
Paralysie récurrentielle induite par la vincristine au cours du traitement d'une maladie de Hodgkin.